NAMUR, Belgium--(BUSINESS WIRE)--Cardiatis S.A., developer and marketer of innovative minimally invasive treatments for thoracoabdominal aortic aneurysms, announced today that two sessions of rapid-fire clinical presentations will be devoted to highlighting the use of its aortic flow modulation technology as minimally invasive endovascular solution for the repair of thoracoabdominal aneurysms. A presentation will be dedicated to discussing three-year outcomes of the Strato study which proved superiority of Cardiatis technology to open surgical repair.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
